Search Tag: Early cancer detection
2025 31 Jul
Interval cancers—those diagnosed within a year following a negative mammogram—pose a significant clinical concern due to their typically aggressive nature and poorer outcomes. Despite the adoption of digital breast tomosynthesis (DBT), which has enhanced several screening performance metrics, its introduction has not led to a statistically significant...Read more
2025 30 Jun
In a strategic move to improve patient outcomes in breast cancer, Affidea , a leading pan-European provider of community-based polyclinics, specialist services and advanced diagnostics, is proud to announce that has selected b-rayZ, a leader in AI-powered breast imaging solutions, as its preferred AI partner for breast imaging. Breast cancer...Read more
2025 30 Jun
In a strategic move to improve patient outcomes in breast cancer, Affidea , a leading pan-European provider of community-based polyclinics, specialist services and advanced diagnostics, is proud to announce that has selected b-rayZ, a leader in AI-powered breast imaging solutions, as its preferred AI partner for breast imaging. Breast cancer...Read more
2025 30 Jun
In a strategic move to improve patient outcomes in breast cancer, Affidea , a leading pan-European provider of community-based polyclinics, specialist services and advanced diagnostics, is proud to announce that has selected b-rayZ, a leader in AI-powered breast imaging solutions, as its preferred AI partner for breast imaging. Breast cancer...Read more
2024 16 Nov
Ovarian cancer (OC) remains a critical health issue globally, particularly as the fifth leading cause of cancer-related deaths among women. Despite its prevalence, OC is often diagnosed at advanced stages, which reduces the chances of successful treatment and survival. In 2020 alone, approximately 314,000 new cases were reported worldwide, underscoring...Read more
2024 16 Nov
Ovarian cancer (OC) remains a critical health issue globally, particularly as the fifth leading cause of cancer-related deaths among women. Despite its prevalence, OC is often diagnosed at advanced stages, which reduces the chances of successful treatment and survival. In 2020 alone, approximately 314,000 new cases were reported worldwide, underscoring...Read more
2024 01 Jul
Artificial intelligence (AI) is reshaping the landscape of mammography, offering significant advancements in early breast cancer detection and mitigating challenges radiologists face. This technology, integrated into imaging systems from leading providers like Hologic, GE Healthcare, Fujifilm Healthcare, and Siemens Healthineers, marks a pivotal...Read more
2024 01 Jul
Artificial intelligence (AI) is reshaping the landscape of mammography, offering significant advancements in early breast cancer detection and mitigating challenges radiologists face. This technology, integrated into imaging systems from leading providers like Hologic, GE Healthcare, Fujifilm Healthcare, and Siemens Healthineers, marks a pivotal...Read more